Literature DB >> 27060645

Pulmonary Rehabilitation in Lung Cancer.

Hongmei Wang1, Xin Liu2, Shawn J Rice2, Chandra P Belani3.   

Abstract

Lung cancer remains a challenging disease with high morbidity and mortality despite targeted therapy. Symptom burden related to cancer impairs quality of life and functional status in patients with lung cancer and in survivors. Pulmonary rehabilitation has been recognized as an effective, noninvasive intervention for patients with chronic respiratory disease. It is well established that pulmonary rehabilitation benefits patients with chronic obstruction pulmonary disease through improved exercise capacity and symptoms. Evidence is increasing that the benefit of pulmonary rehabilitation can be applied to patients with lung cancer. Comprehensive pulmonary rehabilitation has made its way as a cornerstone of integrated care for patients with lung cancer. LEVEL OF EVIDENCE: V.
Copyright © 2016 American Academy of Physical Medicine and Rehabilitation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27060645     DOI: 10.1016/j.pmrj.2016.03.010

Source DB:  PubMed          Journal:  PM R        ISSN: 1934-1482            Impact factor:   2.298


  6 in total

Review 1.  Effect of Pulmonary Rehabilitation on Postoperative Clinical Status in Patients with Lung Cancer and Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis.

Authors:  Lu Wang; Mingwei Yu; Yunfei Ma; Rong Tian; Xiaomin Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-28       Impact factor: 2.650

2.  [Can Preoperative Peak Expiratory Flow Predict Postoperative Pulmonary Complications in Lung Cancer Patients Undergoing Lobectomy?]

Authors:  Kun Zhou; Yanming Wu; Jianhua Su; Yutian Lai; Cheng Shen; Pengfei Li; Guowei Che
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2017-09-20

3.  Molecular designing, virtual screening and docking study of novel curcumin analogue as mutation (S769L and K846R) selective inhibitor for EGFR.

Authors:  Noor Ahmad Shaik; Huda M Al-Kreathy; Ghada M Ajabnoor; Prashant Kumar Verma; Babajan Banaganapalli
Journal:  Saudi J Biol Sci       Date:  2018-05-25       Impact factor: 4.219

4.  Preoperative maximal voluntary ventilation, hemoglobin, albumin, lymphocytes and platelets predict postoperative survival in esophageal squamous cell carcinoma.

Authors:  Shou-Jia Hu; Xue-Ke Zhao; Xin Song; Ling-Ling Lei; Wen-Li Han; Rui-Hua Xu; Ran Wang; Fu-You Zhou; Liang Wang; Li-Dong Wang
Journal:  World J Gastroenterol       Date:  2021-01-28       Impact factor: 5.742

Review 5.  International consensus on severe lung cancer-the first edition.

Authors:  Chengzhi Zhou; Shiyue Li; Jun Liu; Qian Chu; Liyun Miao; Linbo Cai; Xiuyu Cai; Yu Chen; Fei Cui; Yuchao Dong; Wen Dong; Wenfeng Fang; Yong He; Weifeng Li; Min Li; Wenhua Liang; Gen Lin; Jie Lin; Xinqing Lin; Hongbing Liu; Ming Liu; Xinlin Mu; Yi Hu; Jie Hu; Yang Jin; Ziming Li; Yinyin Qin; Shengxiang Ren; Gengyun Sun; Yihong Shen; Chunxia Su; Kejing Tang; Lin Wu; Mengzhao Wang; Huijuan Wang; Kai Wang; Yuehong Wang; Ping Wang; Hongmei Wang; Qi Wang; Zhijie Wang; Xiaohong Xie; Zhanhong Xie; Xin Xu; Fei Xu; Meng Yang; Boyan Yang; Xiangjun Yi; Xiaoqun Ye; Feng Ye; Zongyang Yu; Dongsheng Yue; Bicheng Zhang; Jian Zhang; Jianqing Zhang; Xiaoju Zhang; Wei Zhang; Wei Zhao; Bo Zhu; Zhengfei Zhu; Wenzhao Zhong; Chunxue Bai; Liangan Chen; Baohui Han; Chengping Hu; Shun Lu; Weimin Li; Yong Song; Jie Wang; Caicun Zhou; Jianying Zhou; Yanbin Zhou; Yuichi Saito; Yoshinobu Ichiki; Hitoshi Igai; Satoshi Watanabe; Sara Bravaccini; Alfonso Fiorelli; Francesco Petrella; Takeo Nakada; Piergiorgio Solli; Nikolaos Tsoukalas; Yuki Kataoka; Taichiro Goto; Rossana Berardi; Jianxing He; Nanshan Zhong
Journal:  Transl Lung Cancer Res       Date:  2021-06

6.  Study on Chronic Obstructive Pulmonary Disease and Lung Cancer: Web of Science-Based Bibliometric and Visual Analysis.

Authors:  LiHong Xu; Peng Wang; YaNi Zhang; MuQi Wang; YaPing Li; WenHui Dang
Journal:  Int J Gen Med       Date:  2022-09-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.